Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Anopheles gambiae odorant-binding protein 1 (AgamOBP1) is a small, soluble protein primarily expressed in the olfactory sensilla of the malaria-carrying mosquito, Anopheles gambiae (Biessmann et al., 2002; UniProt P83463). It belongs to the PBP/GOBP family and plays a critical role in the mosquito's ability to locate human hosts by binding and transporting volatile organic compounds, such as indole and other components of human sweat, across the aqueous sensillar lymph to olfactory receptors (Wogulis et al., 2006). Structurally, AgamOBP1 is characterized by a scaffold of six alpha-helices stabilized by three conserved disulfide bonds, forming a central hydrophobic pocket for ligand binding (Wogulis et al., 2006). Because AgamOBP1 is essential for the host-seeking behavior of the primary malaria vector, it is a major target for the development of novel insect repellents and attractants (Tsitsanou et al., 2012). Chemical agents like DEET and Icaridin have been shown to interact with AgamOBP1, disrupting the mosquito's olfactory signaling pathways and thereby reducing the transmission of Plasmodium parasites (Murphy et al., 2013). Understanding the molecular interactions within the AgamOBP1 binding pocket is vital for designing more effective and environmentally safe vector control strategies (Drakou et al., 2017).
AgamOBP1 functions as a carrier for hydrophobic odorants through the aqueous environment of the sensillar lymph to the olfactory receptors on the dendrites of olfactory sensory neurons (Wogulis et al., 2006). Repellents like DEET and Icaridin bind to the same hydrophobic cavity as natural ligands, such as indole, thereby competitively inhibiting the transport of host-seeking cues or inducing conformational changes that alter the mosquito's perception of these cues (Tsitsanou et al., 2012; Murphy et al., 2013).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anopheles gambiae odorant-binding protein 1 (AgamOBP1).